Retlira Retatrutide Peptide Pen 30mg

RETLIRA is a powerful triple-action peptide therapy containing 30mg of Retatrutide, a new-generation weight loss compound targeting:
GLP-1 receptors – reduces appetite and stabilizes blood sugar
GIP receptors – improves insulin sensitivity
Glucagon receptors – boosts fat burning and metabolism
RETLIRA mimics three key metabolic hormones in one weekly injection,
outperforming older GLP-1 options like Semaglutide and Tirzepatide.

High-strength Retatrutide – clinically backed for fat loss & amp; glucose control
Convenient pre-filled 30mg pen
Ideal for those who’ve plateaued on Semaglutide or Tirzepatide
Supports long-term appetite regulation, visceral fat loss, and insulin
improvement
Used in cutting-edge obesity protocols
Triple action. One injection. Total transformation.

Dosing Adjustable dial, 2.5mg–10mg per week
Injection Type Subcutaneous (abdomen, thigh, upper arm)
Use Once per week
Storage Refrigerate unopened (2–8°C). Store up to 30 days, once opened at below 25°C.

Format Prefilled, dial-dose pen (multi-week use)
One pen lasts 2 to 12 weeks, depending on dosage. Use once weekly on the same day each week.